Perioperative use of glucose containing solutions in infants less than 6 months of age : A clinical practice survey among US academic centers
© 2022 John Wiley & Sons Ltd..
BACKGROUND: Although there is a wide breadth of literature on glucose homeostasis in infants, standardization of perioperative hypoglycemia diagnosis and management is lacking.
AIMS: Survey of academic pediatric anesthesiology departments across the USA to evaluate institutional policies regarding the perioperative use of glucose containing solutions in infants less than 6 months of age.
METHODS: A questionnaire was sent to 20 United States university affiliated academic pediatric anesthesiology departments.
RESULTS: The responses suggest that, in the centers surveyed, glucose administration in infants is largely practitioner dependent. Two respondents (10%) claim to have a departmental policy regarding glucose administration in infants less than 6 months of age. In premature infants, 75% of respondents administer glucose. When administering glucose, 75% of physicians surveyed replete infants at their maintenance intravenous fluid rate. There was discrepancy among practitioners regarding initiation of hypoglycemia treatment, 35% treat infants at a blood glucose level of 70 mg/dl, 30% at BG 60 mg/dl, 25% at 50 mg/dl, and 10% are unsure.
DISCUSSION: This survey highlights the lack of consensus, at least among pediatric anesthesiologists working in US academic centers, regarding blood glucose management in infants less than 6 months of age. There is a need to define the indications for using glucose containing solutions in infants during the perioperative period, their ideal content, the appropriate thresholds for hypo- and hyperglycemia as well as the optimal point-of care glucose monitoring intervals.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Paediatric anaesthesia - 32(2022), 5 vom: 02. Mai, Seite 625-630 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Salik, Irim [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adverse events |
|---|
| Anmerkungen: |
Date Completed 26.04.2022 Date Revised 12.05.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/pan.14420 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM337021422 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM337021422 | ||
| 003 | DE-627 | ||
| 005 | 20231225233452.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/pan.14420 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1123.xml |
| 035 | |a (DE-627)NLM337021422 | ||
| 035 | |a (NLM)35170173 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Salik, Irim |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Perioperative use of glucose containing solutions in infants less than 6 months of age |b A clinical practice survey among US academic centers |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.04.2022 | ||
| 500 | |a Date Revised 12.05.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 John Wiley & Sons Ltd. | ||
| 520 | |a BACKGROUND: Although there is a wide breadth of literature on glucose homeostasis in infants, standardization of perioperative hypoglycemia diagnosis and management is lacking | ||
| 520 | |a AIMS: Survey of academic pediatric anesthesiology departments across the USA to evaluate institutional policies regarding the perioperative use of glucose containing solutions in infants less than 6 months of age | ||
| 520 | |a METHODS: A questionnaire was sent to 20 United States university affiliated academic pediatric anesthesiology departments | ||
| 520 | |a RESULTS: The responses suggest that, in the centers surveyed, glucose administration in infants is largely practitioner dependent. Two respondents (10%) claim to have a departmental policy regarding glucose administration in infants less than 6 months of age. In premature infants, 75% of respondents administer glucose. When administering glucose, 75% of physicians surveyed replete infants at their maintenance intravenous fluid rate. There was discrepancy among practitioners regarding initiation of hypoglycemia treatment, 35% treat infants at a blood glucose level of 70 mg/dl, 30% at BG 60 mg/dl, 25% at 50 mg/dl, and 10% are unsure | ||
| 520 | |a DISCUSSION: This survey highlights the lack of consensus, at least among pediatric anesthesiologists working in US academic centers, regarding blood glucose management in infants less than 6 months of age. There is a need to define the indications for using glucose containing solutions in infants during the perioperative period, their ideal content, the appropriate thresholds for hypo- and hyperglycemia as well as the optimal point-of care glucose monitoring intervals | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a adverse events | |
| 650 | 4 | |a age | |
| 650 | 4 | |a complications | |
| 650 | 4 | |a fluids | |
| 650 | 4 | |a infant | |
| 650 | 7 | |a Blood Glucose |2 NLM | |
| 650 | 7 | |a Glucose |2 NLM | |
| 650 | 7 | |a IY9XDZ35W2 |2 NLM | |
| 700 | 1 | |a Doherty, Tara |e verfasserin |4 aut | |
| 700 | 1 | |a Kelley, Ashley |e verfasserin |4 aut | |
| 700 | 1 | |a Jacoby, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Mehta, Bhupen |e verfasserin |4 aut | |
| 700 | 1 | |a Pryjdun, Olena |e verfasserin |4 aut | |
| 700 | 1 | |a Mclean, Maranatha |e verfasserin |4 aut | |
| 700 | 1 | |a Barst, Samuel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Paediatric anaesthesia |d 1997 |g 32(2022), 5 vom: 02. Mai, Seite 625-630 |w (DE-627)NLM074660497 |x 1460-9592 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2022 |g number:5 |g day:02 |g month:05 |g pages:625-630 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/pan.14420 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2022 |e 5 |b 02 |c 05 |h 625-630 | ||